NinaM.ClarkMD
Infectious Disease • Maywood, ILAssociate Professor, Medicine, Loyola University Chicago Stritch School of Medici
Are you Dr. Clark?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 60 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2160 S 1st Ave
Loyola University Health System Fahey Center Rm 112
Maywood, IL 60153Phone+1 708-216-3232Fax+1 708-216-8198
Summary
- Dr. Nina Clark, MD is an infectious disease specialist in Maywood, Illinois. She is currently licensed to practice medicine in Illinois and Michigan. She is affiliated with Loyola University Medical Center and University of Illinois Hospital.
Education & Training
University of MichiganFellowship, Infectious Disease, 1991 - 1993- University of MichiganResidency, Internal Medicine, 1988 - 1991
University of Illinois College of MedicineClass of 1988
Certifications & Licensure
IL State Medical License 2003 - 2026
MI State Medical License 1991 - 2004- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- West Suburban Living Magazine Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- Characterizing the urobiome in geriatric males with chronic indwelling urinary catheters: an exploratory longitudinal study.Emma Stewart, Baylie R Hochstedler-Kramer, Mark Khemmani, Nina M Clark, Jorge P Parada
Microbiology Spectrum. 2024-11-05 - Cefepime-Taniborbactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination.George G Zhanel, Celine Mansour, Stacey Mikolayanko, Courtney K Lawrence, Sheryl Zelenitsky
Drugs. 2024-10-01 - 1 citationsEvidence of SARS-CoV-2 convergent evolution in immunosuppressed patients treated with antiviral therapies.Shuchen Feng, Gail E Reid, Nina M Clark, Amanda Harrington, Susan L Uprichard
Virology Journal. 2024-05-07
Grant Support
- Peri-Kb Mediates HIV-2 Enhancer Activation In MonocytesNational Institute Of Allergy And Infectious Diseases1994–1996
